发明名称 Pharmaceutical Compositions Comprising Gingiva A-Derived Mesenchymal Stem Cells and Methods of Treating Inflammation, Wound Healing and Contact Hypersensitivity
摘要 Disclosed are methods of polarizing macrophages to exhibit M2 phenotype, including introducing an effective amount of gingiva-derived mesenchymal stem cells to an environment comprising a population of macrophages such that the macrophages are in fluid communication with the gingiva-derived mesenchymal stem cells. Also disclosed are methods of promoting cutaneous wound healing including administering to a patient an effective amount of human gingiva-derived mesenchymal stem cells, thereby resulting in at least one of accelerated wound closure, rapid re-epithelialization, improved angiogenesis and improved tissue remodeling relative to untreated controls. Also disclosed are methods for attenuating contact hypersensitivity in a patient, the methods including administering to a patient an effective amount of human gingiva-derived mesenchymal stem cells at a time at least timeframe selected from the group consisting of before sensitization, after sensitization and before challenge and after challenge, thereby attenuating contact hypersensitity.
申请公布号 US2013295058(A1) 申请公布日期 2013.11.07
申请号 US201113809876 申请日期 2011.07.14
申请人 LE ANH D.;ZHANG QUNZHOU;UNIVERSITY OF SOUTHERN CALIFORNIA 发明人 LE ANH D.;ZHANG QUNZHOU
分类号 A61K35/28 主分类号 A61K35/28
代理机构 代理人
主权项
地址